InvestorsHub Logo
Followers 27
Posts 675
Boards Moderated 0
Alias Born 07/26/2017

Re: flipper44 post# 192062

Wednesday, 10/03/2018 1:07:34 PM

Wednesday, October 03, 2018 1:07:34 PM

Post# of 698597
Hi Flip, it would appear by this article that Susan Bayh is receiving cutting edge treatment from Duke that involves chemo, radiation and one of their experimental immunotherapy treatments.
The Bayh's selection of Duke's treatment over UCLA's treatment may just be due to location but we cannot be sure what immunotherapy option she has chosen and any selection of experimental treatments would have been carefully looked at by the Bahys. This may or may not have included DCVAX and again I am sure they would have received opinions quite possibly from NWBO before final selection was made.
Would NWBO disclose the reasons as to why a former BOD did not choose their treatment option, not sure, but the question as to why she chose DUKE over UCLA is a legitimate one and concerning to many longs.

https://www.wthr.com/article/exclusive-family-finds-strength-and-hope-after-susan-bayhs-cancer-diagnosis
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News